Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
United States Revenue	3.02B	2.57B
United States Revenue Growth	17.64%	9.52%
Outside of United States Revenue	223.84M	189.09M
Outside of United States Revenue Growth	18.38%	23.37%
Revenue (Total)	3.25B	2.76B
Revenue (Total) Growth	17.69%	10.37%

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Screening Medicare Parts B & C Revenue	955.08M	776.16M
Screening Medicare Parts B & C Revenue Growth	23.05%	10.66%
Screening Commercial Revenue	1.32B	1.12B
Screening Commercial Revenue Growth	18.32%	12.71%
Screening Other Service Revenue	251.58M	209.38M
Screening Other Service Revenue Growth	20.16%	22.40%
Total Screening Revenue	2.53B	2.10B
Total Screening Revenue Growth	20.25%	12.83%
Precision Oncology Medicare Parts B & C Revenue	196.47M	187.95M
Precision Oncology Medicare Parts B & C Revenue Growth	4.53%	-0.39%
Precision Oncology Commercial Revenue	196.17M	190.60M
Precision Oncology Commercial Revenue Growth	2.93%	5.12%
Precision Oncology International Revenue	223.84M	189.09M
Precision Oncology International Revenue Growth	18.38%	23.37%
Precision Oncology Other Service Revenue	100.64M	87.36M
Precision Oncology Other Service Revenue Growth	15.20%	-17.45%
Total Precision Oncology Revenue	717.12M	655.00M
Total Precision Oncology Revenue Growth	9.49%	4.12%
Revenue (Total)	3.25B	2.76B
Revenue (Total) Growth	17.69%	10.37%

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
United States Income Before Tax	-220.01M	-1.04B
Outside of United States Income Before Tax	16.12M	145.00K
Outside of United States Income Before Tax Growth	11018.62%	-93.91%

Updated Dec 31, 2025. Data Source: Fiscal.ai.